Regulation of [ 3H]D-aspartate release by the 5-F 2t-isoprostane and its 5-epimer in isolated bovine retina

Neurochemical Research

Volumn 37, Issue 3, 2012, Pages 574-582

  Jamil, Jamal ^a   Wright, Ashley ^a   Harrison, Na'Cara ^a   Kegey, Edem ^a   Flowers, Arnecia Faye ^a   Flyod, Namonique Jarell ^a   Kotera, Casey ^a   Guy, Alexandre ^b   Galano, Jean Marie ^b   Durand, Thierry ^b   Njie Mbye, Ya Fatou ^c   Ohia, Sunny E ^c   Opere, Catherine A ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

3H D aspartate; Excitatory neurotransmitter; Isoprostanes; Neurotransmitter release; Prostanoid receptors; Retina

Indexed keywords

5 F 2T ISOPROSTANE; ASPARTIC ACID; EPIMERASE; ISOPROSTANE DERIVATIVE; POTASSIUM; PROSTAGLANDIN E RECEPTOR 4; PROSTANOID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CITRIC ACID CYCLE; CONTROLLED STUDY; COW; ENZYME RELEASE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; OSMOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ANIMALS; CATTLE; D-ASPARTIC ACID; F2-ISOPROSTANES; RETINA; TRITIUM;

BOVINAE; MAMMALIA;

EID: 84862845961     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0645-5     Document Type: Article

References (67)

1. Morrow JD, Hill KE, Burk RF et al (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci 87:9383-9387 (Pubitemid 120030630)
2. Cracowski JL, Stanke-Labesque F, Bessard G (2000) Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects. Rev Med Interne 21(3):304-307 Review (Pubitemid 30434102)
3. Jahn U, Galano JM, Durand T (2008) Beyond prostaglandins-chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids. Angew Chem Int Ed Engl 47:5894-5955
4. Pratico D, Lawson JA, FitzGerald GA (1995) Cyclooxygenasedependent formation of the isoprostane, 8-epi prostaglandin F2 alpha. J Biol Chem 270:9800-9808
5. Patrignani P, Santini G, Panara MR, Sciulli MG, Greco A, Rotondo MT, di Giamberardino M, Maclouf J, Ciabattoni G, Patrono C (1996) Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation. Br J Pharmacol 118:1285-1293 (Pubitemid 26235630)
6. Praticó D, FitzGerald GA (1996) Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem 271:8919-8924
7. Jourdan KB, Mitchell JA, Evans TW (1997) Release of isoprostanes by human pulmonary artery in organ culture: a cyclo-oxygenase and nitric oxide dependent pathway. Biochem Biophys Res Commun 233:668-672 (Pubitemid 27217709)
8. Jourdan KB, Evans TW, Goldstraw P, Mitchell JA (1999) Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release. FASEB J 13(9):1025-1030 (Pubitemid 29249727)
9. Roberts LJ 2nd, Brame CJ, Chen Y, Morrow JD (1999) Novel eicosanoids. Isoprostanes and related compounds. Methods Mol Biol 120:257-285
10. Waugh RJ, Morrow JD, Roberts LJ 2nd, Murphy RC (1997) Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat. Free Rad Biol Med 23:943-954 (Pubitemid 27402620)
11. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ II, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC (2005) Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38:698-710 (Pubitemid 40249740)
12. Opere CA, Ford K, Zhao M, Ohia SE (2008) Regulation of neurotransmitter release from ocular tissues by isoprostanes. Methods Find Exp Clin Pharmacol 30(9):697-701 Review
13. Janssen LJ (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280(6):L1067-L1082 (Pubitemid 32553245)
14. Elmhurst JL, Betti PA, Rangachari PK (1997) Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors. J Pharmacol Exp Ther 282(3):1198-1205 (Pubitemid 27408295)
15. Sametz W, Hennerbichler S, Glaser S, Wintersteiger R, Juan H (2000) Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations. Br J Pharmacol 130: 1903-1910 (Pubitemid 30655803)
16. Kromer BM, Tippins JR (1996) Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Br J Pharmacol 119(6):1276-1280 (Pubitemid 26386001)
17. Hou X, Gobeil F Jr, Peri K, Speranza G, Marrache AM, Lachapelle P, Roberts J 2nd, Varma DR, Chemtob S, Ellis EF (2000) Augmented vasoconstriction and thromboxane formation by 15-F(2t)isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels. Stroke 31(2):516-524
18. Lahaie I, Hardy P, Hou X, Hassessian H, Asselin P, Lachapelle P, Almazan G, Varma DR, Morrow JD, Roberts LJ 2nd, Chemtob S (1998) A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol 274(5 Pt 2):R1406-16
19. Marley R, Harry D, Anand R et al (1997) 8-Isoprostaglandin F2a, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats. Gastroenterology 112:208-213 (Pubitemid 27009004)
20. Daray FM, Colombo JR, Kibrik JR, Errasti AE, Pelorosso FG, Nowak W, Cracowski JL, Rothlin RP (2006) Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein. Naunyn Schmiedebergs Arch Pharmacol 373(5):367-375 (Pubitemid 44215583)
21. Tanito M, Yoshida Y, Kaidzu S, Ohira A, Niki E (2006) Detection of lipid peroxidation in light-exposed mouse retina assessed by oxidative stress markers, total hydroxyoctadecadienoic acid and 8-iso-prostaglandin F2alpha. Neurosci Lett 398(1-2):63-68
22. Dentchev T, Yao Y, Pratico D, Dunaief J (2007) Isoprostane F2alpha-VI, a new marker of oxidative stress, increases following light damage to the mouse retina. Mol Vis 13:190-195 (Pubitemid 46232111)
23. LeDay AM, Kulkarni KH, Opere CA, Ohia SE (2004) Arachidonic acid metabolites and peroxide-induced inhibition of [3H]Daspartate release from bovine isolated retinae. Current Eye Res 28(5):367-372 (Pubitemid 38638812)
24. Nourooz-Zadeh J, Pereira P (2000) F(2) isoprostanes, potential specific markers of oxidative damage in human retina. Ophthalmic Res 32(4):133-137 (Pubitemid 30303699)
25. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Hollo G, Katsimbris IE, Georgiadis N, Ritch R (2003) 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 87(3): 353-356 (Pubitemid 36307914)
26. Opere CA, Awe SO, Harris LC, LeDay AM, Ohia SE (2001) Potentiation of sympathetic neurotransmission in bovine isolated irides by isoprostanes. Free Radic Res 35:257-264 (Pubitemid 32734227)
27. Awe SO, Opere CA, Harris LC, Uketui AJ, Ohia SE (2000) Effect of isoprostanes on sympathetic neurotransmission in the human isolated iris-ciliary body. Neurochem Res 25:491-496 (Pubitemid 30317681)
28. Wang RF, Lee PY, Mittag TW, Podos SM, Serle JB, Becker B (1998) Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys. Arch Ophthalmol 116(9):1213-1216 (Pubitemid 29106444)
29. Gabelt BT, Seeman JL, Podos SM, Mittag TW, Kaufman PL (2004) Aqueous humor dynamics in monkeys after topical 8-iso PGE (2). Invest Ophthalmol Vis Sci 45(3):892-899 (Pubitemid 38868388)
30. Liu H, Zhao M, Opere CA (2008) Prejunctional inhibitory effects of isoprostanes on dopaminergic neurotransmission in bovine retinae, in vitro. Neurochem Res 33(1):37-42 (Epub 2007 Aug 3) (Pubitemid 350242788)
31. Zhao M, Destache CJ, Ohia SE, Opere CA (2009) Role of prostanoid production and receptors in the regulation of retinal endogenous amino acid neurotransmitters by 8-isoprostaglandin E2, ex vivo. Neurochem Res 34(12):2170-2180 (Epub ahead of print)
32. Opere CA, Zheng WD, Huang J, Adewale A, Kruglet M, Ohia SE (2005) Dual effect of isoprostanes on the release of [3H]Daspartate from isolated bovine retinae: role of arachidonic acid metabolites. Neurochem Res 30(1):129-137 (Pubitemid 40254213)
33. Sucher NJ, Lipton SA, Dreyer EB (1997) Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 37:3483-3493 (Pubitemid 27491629)
34. Otori Y, Wei JY, Barnstable C (1998) Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci 39:972-981 (Pubitemid 28196682)
35. Wang X, Ng YK, Tay SS (2005) Factors contributing to neuronal degeneration in retinas of experimental glaucomatous rats. J Neurosci Res 82:674-689 (Pubitemid 41740468)
36. Durand T, Cracowski JL, Guy A, Rossi JC (2001) Syntheses and preliminary pharmacological evaluation of the two epimers of the 5-F2t-Isoprostane. Bioorg Med Chem Lett 11:2495-2498 (Pubitemid 32823341)
37. Opere CA, Jamil JM, Wright A, Durand T, Galano JM, Guy A, Njie-Mbye YF, Ohia SE (2010) Regulation of [3H]D-aspartate release by neuroprostanes in bovine retina, in vitro. ARVO Meeting Abstracts 51:3315
38. Kegey E, Jamil J, Harrison N, Durand T, Galano JM, Guy A, Njie-Mbye YF, Ohia SE, Opere CA (2011) Role of prostanoid receptors in the inhibitory effect of synthetic isoprostanes on potassium-induced [3H]D-aspartate release in isolated bovine retina. FASEB J 25:799.4
39. Ohia SE, Opere CA, Awe SO, Adams L, Shariff NA (2000) Human, bovine and rabbit retinal glutamate-induced [3H]Daspartate release: role in excitotoxicity. Neuro chem Res 25: 853-860 (Pubitemid 30625517)
40. López-Colomé AM, Roberts PJ (1987) Effect of excitatory amino acid analogues on the release of D-[3H]aspartate from chick retina. Eur J Pharmacol 142(3):409-417 (Pubitemid 18063960)
41. Lopez-Colome A, Somohano F (1986) Effect of selective kainate lesions on the release of glutamate and aspartate from check retina. J Neurosci Res 15:205-216 (Pubitemid 16168214)
42. Storm-Mathisen J (1981) Autoradiographic and microchemical localization of high affinity glutamate uptake. In: Roberts P, Storm-Mathisen J, Johnston C (eds) Glutamate: transmitter in the central nervous system. Wiley, New York, pp 89-115
43. Santos PF, Duarte CB, Carvalho AP (1996) Glutamate receptor agonists evoked Ca(2+)-dependent and Ca(2+) independent release of [3H]D-aspartame from cultured chick retina cells. Neurochem Res 21:361-368
44. Kawikova I, Barnes PJ, Takahashi T et al (1996) 8-epi-PGF2a, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am J Respir Crit Care Med 153:590-596
45. Abramovitz M, Adam M, Boie Y et al (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochem Biophys Acta 1483:285-293 (Pubitemid 30029060)
46. Woodward DF, Pepperl DJ, Burkey TH et al (1995) 6-Isopropoxy-9- oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist. Biochem Pharmacol 50:1731-1733
47. Coleman RA, Kennedy I, Sheldrick RLG (1985) AH6809, a prostanoid EP1 receptor blocking drug. Br J Pharmacol 85:273P
48. Michoud E, Lecomte M, Lagarde M, Miernsperger N (1998) In vivo effect of 8-epi-PGF2a on retinal circulation in diabetic and non-diabetic rats. Prostaglandins Leukot Essent Fatty Acids 59(6):349-355 (Pubitemid 29101185)
49. Janssen LJ, Tazzeo T (2002) Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 301(3):1060-1066 (Pubitemid 34595098)
50. Hou X, Roberts LJ 2nd, Gobeil F Jr, Taber D, Kanai K, Abran D, Brault S, Checchin D, Sennlaub F, Lachapelle P, Varma D, Chemtob S (2004) Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature. Free Radic Biol Med 36(2):163-172 (Pubitemid 38117234)
51. Marlière S, Cracowski JL, Durand T, Chavanon O, Bessard J, Guy A, Stanke-Labesque F, Rossi JC, Bessard G (2002) The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein. Br J Pharmacol 135(5):1276-1280 (Pubitemid 34259130)
52. Hellberg MR et al (2001) Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist. Survey Ophthalml 47(Suppl 1): S13-S33 (Pubitemid 35232216)
53. Ungrin MD, Carrière MC, Denis D, Lamontagne S, Sawyer N, Stocco R, Tremblay N, Metters KM, Abramovitz M (2001) Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor. Mol Pharmacol 59(6):1446-1456 (Pubitemid 32510110)
54. Resul B, Stjernschantz J, Selén G, Bito L (1997) Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids. Surv Ophthalmol 41(Suppl 2):S47-S52 Review (Pubitemid 27154524)
55. Sametz W, Hennerbichler S, Glaser S et al (2000) Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations. Br J Pharmacol 130:1903-1910 (Pubitemid 30655803)
56. Nakamura K, Okada S, Ono K, Yokotani K (2003) Effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F2 alpha on the release of noradrenaline from the isolated rat stomach. Eur J Pharmacol 470(1-2):73-78 (Pubitemid 36638627)
57. Clarke DL, Giembycz MA, Patel HJ, Belvisi MG (2004) E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype. Br J Pharmacol 141(4):600-609 Epub 2004 Jan 26 (Pubitemid 38453251)
58. Yura T, Fukunaga M, Grygorczyk R et al (1995) Molecular and functional evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2. Adv Prostaglandin Thromboxane Leukot Res 23:237-239
59. Kyveris A, Maruscak E, Senchyna M (2002) Optimization of RNA isolation from human ocular tissues and analysis of prostanoid receptor mRNA expression using RT-PCR. Mol Vis 8:51-58 (Pubitemid 36153590)
60. Schlotzer-Schrehardt U, Zenkel M, Nusing RM et al (2002) Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci 43(5):1475-1487 (Pubitemid 34462647)
61. Wright WS, McElhatten RM, Harris NR (2009) Expression of thromboxane synthase and the thromboxane-prostanoid receptor in the mouse and rat retina. Exp Eye Res 89(4):532-537 (Epub 2009 June 11)
62. Sharif NA, Williams GW, Crider JY, Xu SX, Davis TL (2004) Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes. J Ocul Pharmacol Ther 20(6):489-508 (Pubitemid 39628495)
63. McKenniff MG, Norman P, Cuthbert NJ, Gardiner PJ (1991) BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro. Br J Pharmacol 104(3):585-590
64. Sugimoto H, Shichijo M, Iino T, Manabe Y, Watanabe A, Shimazaki M, Gantner F, Bacon KB (2003) An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther 305(1):347-352 (Pubitemid 36373870)
65. Fukunaga M, Makita N, Roberts LJ II et al (1993) Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 264(6 Pt 1):C1619-C1624 (Pubitemid 23198533)
66. Joy AP, Cowley EA (2008) 8-iso-PGE2 stimulates anion efflux from airway epithelial cells via the EP4 prostanoid receptor. Am J Respir Cell Mol Biol 38(2):143-152 (Pubitemid 351162835)
67. Bertram KM, Bula DV, Pulido JS et al (2008) Amino-acid levels in subretinal and vitreous fluid of patients with retinal detachment. Eye (Lond) 22(4):582-589 (Pubitemid 351560424)